Artwork

Content provided by iHeartPodcasts and Pushkin Industries and Pushkin Industries. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by iHeartPodcasts and Pushkin Industries and Pushkin Industries or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

Fighting Cancer with CRISPR

34:41
 
Share
 

Manage episode 419756344 series 3379085
Content provided by iHeartPodcasts and Pushkin Industries and Pushkin Industries. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by iHeartPodcasts and Pushkin Industries and Pushkin Industries or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

Last year, the FDA approved a treatment for sickle cell disease using a revolutionary new gene editing technology called CRISPR. Rachel Haurwitz conducted pioneering research on CRISPR as a graduate student. Now she’s the co-founder and CEO of Caribou Biosciences. Rachel's problem is this: How can you improve CRISPR and use it to engineer human immune cells to fight cancer?

See omnystudio.com/listener for privacy information.

  continue reading

119 episodes

Artwork
iconShare
 
Manage episode 419756344 series 3379085
Content provided by iHeartPodcasts and Pushkin Industries and Pushkin Industries. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by iHeartPodcasts and Pushkin Industries and Pushkin Industries or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

Last year, the FDA approved a treatment for sickle cell disease using a revolutionary new gene editing technology called CRISPR. Rachel Haurwitz conducted pioneering research on CRISPR as a graduate student. Now she’s the co-founder and CEO of Caribou Biosciences. Rachel's problem is this: How can you improve CRISPR and use it to engineer human immune cells to fight cancer?

See omnystudio.com/listener for privacy information.

  continue reading

119 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide